Fujian Medical University Union Hospital: Breast Neoplasms trials
The registry lists 11 Breast Neoplasms studies with Fujian Medical University Union Hospital as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 2 4Phase 3 1Phase 4 1No phase 5(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Internal Mammary Lymph Nodes Irradiation in High-risk Breast Cancer After Neoadjuvant ChemotherapyRecruitingNCT06559696Phase 3
- Effect of Neoadjuvant Chemotherapy on Cardiac Function of Perioperative Patients With Breast Cancer and New Strategies for AnesthesiaRecruitingNCT06497660Phase 4
- PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer PatientsRecruitingNCT05704166Phase 2
- Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast CancerRecruitingNCT05292742Phase 2
- Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter StudyActive, not recruitingNCT07032220Not applicable
- Timing of Surgery and the Evolution of Postoperative Outcomes in Breast Cancer Patients Undergoing Surgical Intervention Following Recovery From SARS-CoV-2 InfectionActive, not recruitingNCT06319209
- Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast CancerCompletedNCT06149377
- Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoadjuvant ChemotherapyStatus unknownNCT05512468Not applicable
- Dalpiciclib Plus Letrozole and CapecitabineStatus unknownNCT05469750Phase 2
- Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast CancerStatus unknownNCT05255523Phase 2
- Relationship Between Genetic Polymorphism and Postoperative Nausea and Vomiting in Chinese Han PopulationCompletedNCT03705026